Product Images Pregabalin

Each capsule of Pregabalin USP 75 contains 75mg of pregabalin. This drug should be kept out of reach of children and stored at room temperature (20°-25°C or 68°-77°F). These capsules are manufactured by ScieGen Pharmaceuticals, Inc. and repackaged by Bryant Ranch Prepack, Inc. This drug is available only by prescription.*

The text seems to contain some numeric values related to patient improvement and pain reduction. However, the characters are not organized and some of them couldn't be identified by the . Therefore, it's not possible to generate a useful description.*

This appears to be a chart showing the percentage of patients who experienced improvement in pain levels after taking a medication called Pregabalin at a dose of 160 mg for a period of 3 days. The chart shows different pain scores at different time intervals (2w, 220, 23, 20, 280, 2, 20, 2w, 23w) and the corresponding percentage of patients who experienced improvement.*

This text appears to be a mix of numerical data and medication names and dosages. It is not clear what the context or purpose of the data is. Thus, the description cannot be provided.*

The text appears to show the names and doses of medications being administered to patients, as well as some data related to their improvement in pain. However, the text contains many errors and is not readable.*

This appears to be a table or graph showing data from multiple studies with different treatment groups and dosages. The names of the studies are E1 and E3, and there is a treatment group labeled S5. The data includes dosage amounts (ranging from placebo to 600mg/day) and a note that the results were statistically significant compared to the placebo group. Therefore, this text appears to be a partial report of clinical trial results for a treatment being studied.*

The text provides a chart that compares the percent of patients improved with a daily dose of Pregabalin 300mg and Pregabalin 450mg. There is another column for the placebo group. The chart also shows the percent of improvement in pain from baseline. No additional information is available.*

This appears to be a chart or table showing estimated percentages of subjects without LTR (potentially related to a medical trial or study) over a certain number of days. The chart includes two groups: one labeled "Progabain" and the other labeled "Placebo". Unfortunately, as can sometimes produce errors when converting text, the exact meaning or context of the chart cannot be confirmed without further information.*

The text is describing a table or graph showing the percentage of subjects who improved after taking either Pregabalin or a placebo for 16 weeks. The chart displays a range of numbers from 100 to 280 and shows that there was a percentage increase in improvement for those taking Pregabalin. However, without additional context or units of measurement, it's challenging to draw further conclusions from the provided text.*

This appears to be a calculation for estimating creatinine clearance using the Cockcroft-Gault formula, which takes into account a person's age, weight, and serum creatinine level. The mm's represent an unknown value that would need to be replaced with a number, and the "e e" likely represents "x 0.85" for female patients. However, without knowing the actual values for age, weight, and serum creatinine, it's not possible to determine an accurate estimate of creatinine clearance.*